Squarepoint
GBT

Squarepoint’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Squarepoint’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-105,305
Closed -$3.36M – 3635
2022
Q2 		$3.36M Buy
105,305
+29,727
+39% +$870K 0.02% 880
2022
Q1 		$2.62M Buy
75,578
+32,148
+74% +$961K 0.01% 994
2021
Q4 		$1.27M Sell
43,430
-8,374
-16% -$259K ﹤0.01% 1534
2021
Q3 		$1.32M Buy
51,804
+38,472
+289% +$1.13M ﹤0.01% 1408
2021
Q2 		$467K Buy
13,332
+1,102
+9% +$43K ﹤0.01% 2180
2021
Q1 		$498K Sell
12,230
-4,789
-28% -$220K ﹤0.01% 2024
2020
Q4 		$737K Buy
17,019
+10,772
+172% +$531K 0.01% 1526
2020
Q3 		$344K Sell
6,247
-40,344
-87% -$2.56M ﹤0.01% 1703
2020
Q2 		$2.94M Buy
46,591
+36,878
+380% +$2.53M 0.05% 504
2020
Q1 		$496K Sell
9,713
-8,982
-48% -$602K 0.01% 1049
2019
Q4 		$1.49M Sell
18,695
-43,051
-70% -$2.55M 0.01% 1079
2019
Q3 		$3M Sell
61,746
-3,637
-6% -$190K 0.03% 662
2019
Q2 		$3.44M Buy
65,383
+44,483
+213% +$2.56M 0.03% 571
2019
Q1 		$1.11M Buy
20,900
+5,760
+38% +$283K 0.01% 1061
2018
Q4 		$621K Sell
15,140
-11,860
-44% -$444K 0.01% 1145
2018
Q3 		$1.03M Sell
27,000
-2,800
-9% -$124K 0.01% 974
2018
Q2 		$1.35M Buy
29,800
+11,400
+62% +$519K 0.02% 773
2018
Q1 		$889K Sell
18,400
-23,494
-56% -$1.31M 0.01% 852
2017
Q4 		$1.65M Buy
+41,894
New +$1.56M 0.03% 628
2017
Q2 		– Sell
-37,606
Closed -$1.39M – 1895
2017
Q1 		$1.39M Buy
37,606
+7,276
+24% +$183K 0.04% 488
2016
Q4 		$438K Buy
+30,330
New +$533K 0.02% 914

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Squarepoint's GBT Position: Q3 2022 in Review

Squarepoint sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 105,305 shares — an estimated $3.36M sold.

Squarepoint first reported a position in GBT in Q4 2016 and held it in 21 quarters. The position peaked at $3.44M in Q2 2019. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Squarepoint reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Squarepoint sold 105,305 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $3.36M.
  • Squarepoint first reported a position in Global Blood Therapeutics, Inc. in Q4 2016 and held it in 21 quarters.
  • Squarepoint's Global Blood Therapeutics, Inc. position peaked at $3.44M in Q2 2019.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Squarepoint's 13F filing for Q3 2022, filed 14 Nov 2022.